- TV Footage
- Integrated Annual Reports
- Quarterly Reports
- Bayer Magazine
- BEENOW Magazine
- Farming’s Future Magazine
- research Magazine
- technology solutions Magazine
- From Molecules to Medicine
- From Molecules to Veterinary Medicines Brochure
- Integrated Weed Management
- Names | Figures | Facts
- Transfers of Value to Physicians Brochure
- Newsletter Overview
- Social Media
- Media Contact
Monheim, November 10, 2016 – Bayer has joined the Centre for Crop Health and Protection (CHAP) located on the National Agri-Food Innovation Campus, Sand Hutton, United Kingdom. The CHAP serves as an international centre for innovation in crop protection uniting public academic institutions and private companies. The partnership will focus on plant health to improve agricultural productivity as a vital aspect of food security.
Whilst the causes of low productivity are complex, one major contributory factor is crop field losses due to plant health problems. CHAP and its partners will advance new long-term solutions for crop health and protection involving the application of the best current scientific techniques as well as the development of new approaches.
“We are excited to work as a partner of CHAP with a clear objective of developing solutions which help farmers to meet diverse challenges such as weed and disease resistance, the impact of climate change, and the need to reduce crop losses in agriculture,” said Dr. Adrian Percy, Head of Research and Development at Crop Science, a Division of Bayer.
Dr. Arnd Nenstiel, Head of Agricultural Policy & Stakeholder Affairs at Crop Science, emphasized that “this partnership will enable us to develop solutions together with food retailers, processors, agronomists and research institutions.”
“Bayer becoming a partner is an exciting opportunity for CHAP,” said Adrian Barraclough, Operating Officer at CHAP. ”The expertise and knowledge that Bayer will bring will not only strengthen what we can offer in crop protection but it will also enhance the development of solutions in global farming.”
Dr. Richard Schmuck, director of Environmental Safety at Crop Science, added: “CHAP will provide Bayer with early access to multiple innovative research institutions and help promote the development of risk-based regulatory frameworks.”
The Centre for Crop Health and Protection (CHAP) was launched in April 2016 after securing more than GBP 21 million of Government funding as part of the Government’s long-term Agri-Tech strategy. It has been established to bring together leading expertise, knowledge and resources from the UK’s foremost research organizations and industries.
Consortium partners from across the UK include Farmcare, Frontier Agriculture, Dow AgroSciences, Tesco, Stockbridge Technology and Unilever, alongside the Agriculture and Horticulture Development Board (AHDB), the Centre for Agriculture and Biosciences International (CABI), Cranfield University, FERA Science Ltd, Newcastle University, ADAS UK Ltd., The Met Office, Warwick University, Campden BRI and Rothamsted Research.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.